• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production.对初次检测结果不确定的住院COVID-19患者进行QuantiFERON-TB Gold Plus检测的纵向评估：炎症消退、T淋巴细胞计数恢复及γ-干扰素产生情况
Microbiol Spectr. 2022 Oct 26;10(5):e0185822. doi: 10.1128/spectrum.01858-22. Epub 2022 Sep 13.
2
Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients.不确定的 QuantiFERON Gold Plus 检测结果揭示了重症 COVID-19 患者干扰素γ反应不足。
J Clin Microbiol. 2021 Sep 20;59(10):e0081121. doi: 10.1128/JCM.00811-21. Epub 2021 Jul 7.
3
Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.一种肝素结合血凝素干扰素-γ释放试验对检测HIV感染患者结核分枝杆菌感染的贡献：与结核菌素皮肤试验和全血γ-干扰素释放试验（QFT-GIT）的比较
BMC Infect Dis. 2015 Feb 14;15:59. doi: 10.1186/s12879-015-0796-0.
4
Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.两种干扰素-γ释放检测方法（QuantiFERON-TB Gold In-Tube和T-SPOT.TB）在HIV感染成人潜伏性结核感染检测中的比较。
Int J STD AIDS. 2013 Oct;24(10):775-9. doi: 10.1177/0956462413486459. Epub 2013 Jul 15.
5
Clinical and Epidemiological Correlates of Low IFN-Gamma Responses in Mitogen Tube of QuantiFERON Assay in Tuberculosis Infection Screening During the COVID-19 Pandemic: A Population-Based Marker of COVID-19 Mortality?COVID-19 大流行期间结核感染筛查中 Mitogen 管 QuantiFERON 检测 IFN-γ 低反应的临床和流行病学相关性：COVID-19 死亡率的基于人群的标志物？
Arch Bronconeumol. 2022 Sep;58(9):649-659. doi: 10.1016/j.arbres.2022.01.011. Epub 2022 Feb 13.
6
Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results.不确定和临界结核感染T细胞检测（Quantiferon Gold TB IGRA）结果的频率及意义
Eur Respir J. 2017 Oct 26;50(4). doi: 10.1183/13993003.01267-2017. Print 2017 Oct.
7
Evaluation of interferon gamma release assay to measure t-cell response in COVID-19 patients from intensive care units and inpatient departments.评估干扰素γ释放试验以测定重症监护病房和住院部COVID-19患者的T细胞反应。
Bratisl Lek Listy. 2024;125(9):533-538. doi: 10.4149/BLL_2024_83.
8
Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples.全血γ-干扰素释放试验和增强版全血γ-干扰素释放试验检测临床样本中结核感染的比较结果
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.01854-19.
9
Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.比较活动性和潜伏性结核病患者使用 QuantiFERON-TB Gold Plus 和 QuantiFERON-TB Gold In-Tube 检测的效果：一项前瞻性队列研究。
J Infect Chemother. 2021 Dec;27(12):1694-1699. doi: 10.1016/j.jiac.2021.08.003. Epub 2021 Aug 16.
10
Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents.用于诊断接受免疫抑制剂治疗患者潜伏性结核感染的系列干扰素-γ释放试验。
Korean J Lab Med. 2011 Oct;31(4):271-8. doi: 10.3343/kjlm.2011.31.4.271. Epub 2011 Oct 3.

引用本文的文献

1
Factors associated with indeterminate QuantiFERON-TB Gold Plus Test results during the COVID-19 pandemic.新冠疫情期间与QuantiFERON-TB Gold Plus检测结果不确定相关的因素。
PLoS One. 2025 Jul 21;20(7):e0326615. doi: 10.1371/journal.pone.0326615. eCollection 2025.
2
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy.意大利罗马托尔韦尔加塔大学综合医院新冠病毒住院患者中病毒与细菌合并感染及家庭抗生素治疗的影响
Antibiotics (Basel). 2023 Aug 22;12(9):1348. doi: 10.3390/antibiotics12091348.
3
COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.COVID-19 相关霉菌感染：COVID-19 相关肺曲霉病和毛霉菌病的综述。
J Microbiol Immunol Infect. 2023 Jun;56(3):442-454. doi: 10.1016/j.jmii.2022.12.004. Epub 2022 Dec 15.

本文引用的文献

1
In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production.在重症新型冠状病毒肺炎患者中，外周血T细胞亚群的显著减少与结核感染T细胞检测（QuantiFERON-TB Gold）阳性不确定率的增加相关，这反映出γ干扰素产生减少。
Life (Basel). 2022 Feb 7;12(2):244. doi: 10.3390/life12020244.
2
Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results.托珠单抗治疗的重症 COVID-19 患者中细胞因子释放综合征对结核菌素纯蛋白衍生物加检测结果的影响。
Arch Bronconeumol. 2021 Apr;57:58-59. doi: 10.1016/j.arbres.2021.02.003. Epub 2021 Feb 13.
3
Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients.新冠肺炎患者中结核感染 T 细胞检测试剂盒（酶联免疫斑点法）检测结果不确定率升高。
J Clin Microbiol. 2021 Sep 20;59(10):e0141421. doi: 10.1128/JCM.01414-21. Epub 2021 Aug 4.
4
Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients.不确定的 QuantiFERON Gold Plus 检测结果揭示了重症 COVID-19 患者干扰素γ反应不足。
J Clin Microbiol. 2021 Sep 20;59(10):e0081121. doi: 10.1128/JCM.00811-21. Epub 2021 Jul 7.
5
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.基线 T 淋巴细胞亚群绝对计数可预测 SARS-CoV-2 感染患者的结局和严重程度：一项单中心研究。
Sci Rep. 2021 Jun 17;11(1):12762. doi: 10.1038/s41598-021-90983-0.
6
Clinical Significance of Indeterminate QuantiFERON-TB Gold Plus Assay Results in Hospitalized COVID-19 Patients with Severe Hyperinflammatory Syndrome.住院的新冠肺炎重症高炎症综合征患者中QuantiFERON-TB Gold Plus检测结果不确定的临床意义
J Clin Med. 2021 Feb 26;10(5):918. doi: 10.3390/jcm10050918.
7
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy.对适合免疫抑制治疗的重症 COVID-19 患者进行 IGRA 检测以诊断结核感染的初步观察。
Respir Med. 2020 Dec;175:106204. doi: 10.1016/j.rmed.2020.106204. Epub 2020 Nov 6.
8
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.严重的免疫抑制，而非细胞因子风暴，是 COVID-19 感染的特征。
JCI Insight. 2020 Sep 3;5(17):140329. doi: 10.1172/jci.insight.140329.
9
On tuberculosis and COVID-19 co-infection.关于结核病和 COVID-19 合并感染。
Eur Respir J. 2020 Aug 20;56(2). doi: 10.1183/13993003.02328-2020. Print 2020 Aug.
10
The (in)significance of TB and COVID-19 co-infection.结核和 COVID-19 合并感染的意义。
Eur Respir J. 2020 Aug 20;56(2). doi: 10.1183/13993003.02105-2020. Print 2020 Aug.

Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production.

作者信息

Alessio Grazia, Imeneo Alessandra, Di Lorenzo Andrea, Rossi Benedetta, Sorace Chiara, Compagno Mirko, Coppola Luigi, Campogiani Laura, Crea Angela Maria Antonia, Malagnino Vincenzo, Buccisano Francesco, Andreoni Massimo, Sarmati Loredana, Iannetta Marco

机构信息

Department of Systems Medicine, Tor Vergata University, Rome, Italy.

Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.

出版信息

Microbiol Spectr. 2022 Oct 26;10(5):e0185822. doi: 10.1128/spectrum.01858-22. Epub 2022 Sep 13.

DOI:10.1128/spectrum.01858-22
PMID:36098523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9602342/
Abstract
摘要